Clara has an interdisciplinary, research-oriented background, holding both a BSc and an MSc with honours in Biomedical Engineering from Politecnico di Milano.
During her Master’s studies, she specialised in bioengineering for cells, tissues, and biotechnology, while consistently integrating her strong biological foundation with technical expertise in artificial intelligence and bioinformatics.
As part of the Erasmus+ programme, she spent six months at the Instituto Superior Técnico in Lisbon, deepening her knowledge of stem cell bioengineering and regenerative medicine. She then carried out her Master’s thesis at the international research centre Human Technopole in Milan, within the Population & Medical Genomics department, where she gained hands-on experience in single-cell multi-omics to study the immune microenvironment in paediatric acute myeloid leukaemia.
Following her degree, Clara worked as an Advanced Analytics Intern at Bayer Italia, applying her multidisciplinary skill set to generate data-driven insights in support of innovation and excellence in the pharmaceutical sector.
Her international and cross-disciplinary experiences have shaped an analytical, detail-oriented mindset that she brings to every project. Driven by a strong fascination for the potential of biological data and emerging technologies, Clara is particularly motivated by their application to precision medicine and patient-centred research. With a genuine desire to make a positive impact, she has recently started her career in pharmaceutical research through a GSK graduate scheme, where she is eager to continue learning, explore diverse roles, and contribute to technological and scientific innovation.
Stefan Seebacher is the IT program lead in the Clinical Trial Supply Program at Boehringer Ingelheim and is based in Biberach, Germany. In his role, he implements and supports data‑driven processes and solutions, working closely with cross‑functional teams to enhance reliability, efficiency, and strategic value within the clinical trial supply IT landscape.
Stefan has a strong academic background in information systems, holding a PhD from Karlsruhe Institute of Technology (KIT).
Michael Hoefling is currently Head of Digitalization and Automation, at Boehringer Ingelheim, based in Biberach, Germany.
He aims at advancing digital transformation and automation across drug product development for NCEs including clinical manufacturing. His work focuses on implementing innovative, robust, and state-of-the-art information technologies that comply with regulatory requirements and enhance efficiency, quality, and sustainability.
Michael is an IEEE Senior Member and holds a strong academic background in computer science, including B.Sc. and M.Sc. degrees from Umeå University (Sweden), a Diplom-Informatiker degree from the University of Wuerzburg (Germany), and a Ph.D. from the University of Tuebingen (Germany).
Hasegawa is a researcher at Morinaga Milk’s Food Function Research Institute who specializes in evaluating the functionality of probiotics. With a background in microbiology and biotechnology, she focuses on uncovering how Bifidobacterium contributes to human health through both clinical and fundamental research approaches.
In this session, she will present the scientific foundation behind the skin‑health benefits of Bifidobacterium breve M‑16V and explain how the strain supports skin wellness.
Kato joined the company in 2011 and has over ten years of experience researching gut bacteria. She has conducted clinical trials evaluating the functionality of probiotic and postbiotic materials, and she currently manages multiple clinical trials. Kato now works at the Functional Foods Research Institute, where she is passionately engaged in clinical research that contributes to the domestic and international development of bacterial materials.
As head of Logistics Engineering I am responsible for Network Design & Flow Optimization, M&A Logistics stream, Master Data Management and strategic projects within the overall global logistics transformation.
In SANOFI we are leading a big transformation program for Global Logistics in which we are concentrating on Digitalization and AI road map, Externalization (4PL, 3PL projcts), Logistics Control Tower implementation and Distribution Footprint optimization
Bernd Steffens is currently IU Sustainability Lead Clinical Trials, at Boehringer Ingelheim, based in Biberach, Germany. His ambition is to contribute to the understanding of environmental impact aspects in clinical trials and their decarbonization. Before that he was for about 30 years Head of the Global Clinical Trial Supplies Unit or related functions in the same company, with focus on Supply Chain Management in general, outsourcing strategies, smart global distribution strategies and digitalization initiatives.
He is chemist by profession with diploma and PhD from the Ruhr-Universitaet Bochum and started in industry with process development in API manufacture.
Ilaria Rondinone is a Clinical Supply Digital & Technology Lead with strong expertise in driving digital transformation across R&D functions. With more than 14 years of experience in clinical supply, clinical operations, she leads strategic initiatives that integrate advanced technologies—such as AI models, smart patient sensors, and track‑and‑trace solutions—to enhance patient-centric clinical trials.
Throughout her career at Chiesi, she has spearheaded innovative approaches including decentralized clinical trial elements and predictive supply models to reduce waste and improve operational efficiency. Her background spans global clinical supply leadership, digital innovation programs, and cross-functional roles bridging clinical, CMC.
Ilaria holds a degree in Pharmaceutical Chemistry and Technology from the University of Parma, a Master in Pharmaceutical Marketing and Management, a Master in Clinical Research Associate and a European Course in Pharmaceutical Medicine (ECPM) from the University of Basel.
Clinical Supply Chain Specialist at mAbxience (Madrid, Spain), Master in Neuroscience.
In this role, she is working within the Clinical Team as well as different international service providers to support the execution of the operational flow, ensuring streamlined drug supply throughout the clinical studies delivering on time, within budget, and of high quality in compliance with ICH/GCP, Regulatory Authorities regulations/guidelines, and applicable Standard Operating Procedures.
For almost a year in mAbxience, in conjunction with her previous role in Immutep since 2019, she brings a wealth of experience in clinical trial supply management, vendor oversight and operational excellence.
Her expertise covers supporting clinical study teams from start up to completion, working with CROs, CMOs and several logistic stakeholders in a very international environment (10 years abroad in between Germany and France), ensuring meeting program timelines with the highest standards of quality and efficiency.
A founding partner of Redcliffe Capital, the firm specializes in investing in and building companies that help enterprises and entrepreneurs leverage innovation in technology such as digital transformation, , Data and Artificial Intelligence. Redcliffe’s investment thesis focuses on the AI First Everything approach. A fundamental change in businesses will emerge in the coming years and provide significant opportunities in every industry.
Alpesh’s career started over 25 years ago after graduating in Computer Science and he now works helping enterprises innovate and implement new technology and business models. He believes that technology tied with business change can transform an enterprise or an industry. He works in the financial services, insurance, energy, telecoms and media and entertainment sectors.
